硫酸肼在晚期癌症患者中的临床研究。
Clinical study of hydrazine sulfate in advanced cancer patients.
作者信息
Spremulli E, Wampler G L, Regelson W
出版信息
Cancer Chemother Pharmacol. 1979;3(2):121-4. doi: 10.1007/BF00254983.
PMID:389477
Abstract
Twenty-five patients with a variety of solid tumors were treated with hydrazine sulfate. Hydrazine was given orally in the form of 60 mg capsules from one to four times daily. No patient had a 50% reduction of tumor size. Subjective benefit was seen in three patients but it was of brief duration.
摘要
25名患有各种实体瘤的患者接受了硫酸肼治疗。硫酸肼以60毫克胶囊的形式口服，每天1至4次。没有患者的肿瘤大小缩小50%。3名患者出现了主观上的益处，但持续时间很短。
Zotero 插件